Search Results 881-890 of 17152 for ibd

  1. Publications - Leslie A. Sim, Ph.D., L.P. - Mayo Clinic

    Eating Disorders: Diagnosis and Management Considerations for the IBD Practice. ... Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2021 Nov; 17 ...

  2. Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3) - Mayo Clinic

    Pregnant, breast-feeding, or considering becoming pregnant during the study · Prior history, evidence, or diagnosis of inflammatory bowel disease (e.g., Crohn's ...

  3. Infliximab-Dyyb (Intravenous Route, Subcutaneous Route) Before Using - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  4. Publications - Eric C. Ehman, M.D. - Mayo Clinic

    ... Inflammatory Bowel Disease. Dermatology 2023; 239 (5):843-848 Epub 2023 June 23. View PubMed; Huls SJ, Burkett B, Ehman E, Lowe VJ, Subramaniam RM, Kendi AT ...

  5. News - William A. Faubion, Jr., M.D. - Mayo Clinic

    Make your tax-deductible gift and be part of the cutting-edge research and care that's changing medicine. Donate.

  6. Multidisciplinary Training in Digestive Diseases - Mayo Clinic

    Enteric neurosciences; Liver pathobiology; Mucosal immunology; Regenerative medicine and stem cells; Transcription and epigenetics. Training in this track is ...

  7. Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer. - Mayo Clinic

    inflammatory bowel disease, vascular thrombosis associated with antiphospholipid syndrome, Wegener's granulomatosis, Sjögren's syndrome, Guillain-Barré ...

  8. Publications - James M. Kofler, Jr., Ph.D. - Mayo Clinic

    ... inflammatory bowel disease. Am J Gastroenterol. 2008 Aug; 103 (8):2015-22 Epub 2008 June 28. View PubMed; McCollough CH, Bruesewitz MR, Kofler JM Jr. CT dose ...

  9. Gastroenterology and Hepatology - Clinical trials

    Rochester, Minn. The purpose of this research study is to improve our understanding of normal liver and gallbladder function and liver and gallbladder diseases ...

  10. SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence - Mayo Clinic

    ... inflammatory bowel disease in the past 12 months. Estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73m2; Admitted to or expected to be admitted to ...